Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways.
about
Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolveCellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor RadiosensitizationSensitization of Pancreatic Cancers to Gemcitabine Chemoradiation by WEE1 Kinase Inhibition Depends on Homologous Recombination RepairRadiosensitizing effect of diosmetin on radioresistant lung cancer cells via Akt signaling pathway.Dissociation of gemcitabine chemosensitization by CHK1 inhibition from cell cycle checkpoint abrogation and aberrant mitotic entry.A signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivity.Twist1 promotes radioresistance in nasopharyngeal carcinoma.Inhibiting DNA-PKCS radiosensitizes human osteosarcoma cells.Comparison of human lung cancer cell radiosensitivity after irradiations with therapeutic protons and carbon ions.Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibitionBiological determinants of radioresistance and their remediation in pancreatic cancer.Differential expression profile analysis of DNA damage repair genes in CD133+/CD133- colorectal cancer cells.Chronic radiation exposure of neuroblastoma cells reduces nMYC copy numberImproving radiotherapy in cancer treatment: Promises and challenges.MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells.Novel DNA targeted therapies for head and neck cancers: clinical potential and biomarkers.Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53.Phytotherapeutics Oridonin and Ponicidin show Additive Effects Combined with Irradiation in Pancreatic Cancer in Vitro.Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells.Inactivation of DNA-PK by knockdown DNA-PKcs or NU7441 impairs non-homologous end-joining of radiation-induced double strand break repair.Etoposide radiosensitizes p53-defective cholangiocarcinoma cell lines independent of their G2 checkpoint efficacies.DNA Repair.Advances in therapeutic targeting of the DNA damage response in cancer.
P2860
Q26764947-B446FF7D-273B-44C1-BE24-80E8AE620A85Q26771165-DE70E9DF-4FB9-432D-BDEC-DF7D27B9F769Q36309585-75C56486-31E7-47C2-8A68-A0E65C7C75F6Q36348567-FF325F5A-4F00-49AA-AF64-F88F5A2AB948Q36838392-6D7057FB-C581-49DC-A5DE-B1592DED2769Q37595154-CD38B0CF-D46B-4895-90EF-6EB13C5EAE75Q37697159-D36869BF-D485-4DF7-850A-33F92BB3EBB9Q38712083-3E40BB1A-E8D4-4F73-A086-997253A85706Q38746087-1A9D3ADC-5D9C-4EF5-A281-7207212C7F49Q38823644-38EB50D1-A342-458C-BD08-D302E2265699Q39156722-F6B4C511-06E7-47B5-AEF6-E119A1E9C191Q41144456-61267D38-0A75-45A9-B9C3-011681ED5E24Q41620256-FEB03A64-8E49-4073-AF85-960516E6898AQ41899048-D2B41A3C-9B5F-486E-8B36-11CC87804E22Q42317541-81135072-93F2-4E37-9E4C-3AA0A9C12AABQ45790068-AA903734-1CA5-41CF-9A4C-C4FA8D209870Q46038047-BBF6ABFA-D364-4B17-A780-651627A06F5DQ47400524-2B560518-8D90-4B4E-9922-9C1ADF3D59F2Q47848908-BAE46025-C334-4B9F-9E7C-8829EB29099AQ49981844-D2A6BB4B-2C63-4F4B-A572-1733C8975922Q52726503-F97C3BA0-8BE8-4D0D-A4DE-C756EEFDC3A7Q52863441-10D63003-D947-485D-8DBC-EE60D985116CQ55306606-9C6A1CAB-55D1-4527-9B25-A9983648CD91
P2860
Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Molecular Pathways: Overcoming ...... DNA Damage Response Pathways.
@en
type
label
Molecular Pathways: Overcoming ...... DNA Damage Response Pathways.
@en
prefLabel
Molecular Pathways: Overcoming ...... DNA Damage Response Pathways.
@en
P2860
P1476
Molecular Pathways: Overcoming ...... DNA Damage Response Pathways.
@en
P2093
Meredith A Morgan
Theodore S Lawrence
P2860
P304
P356
10.1158/1078-0432.CCR-13-3229
P407
P577
2015-07-01T00:00:00Z